From: HBP-enhancing hepatocellular adenomas and how to discriminate them from FNH in Gd-EOB MRI
Reader 1 | Reader 2 | |||||
---|---|---|---|---|---|---|
ROC/AUC | Sens./Spec | PPV/NPV | ROC/AUC | Sens./Spec | PPV/NPV | |
Gd-EOB uptake behavior (1) | 0.848 | 82.0/87.5 | 82.0/87.5 | 0.920 | 96.5/87.5 | 84.5/97.0 |
Gd-EOB uptake pattern (1) | 0.614 | 93.0/30.0 | 48.0/86.0 | 0.641 | 86.0/42.5 | 51.0/81.0 |
Art. Hyperenhancement (1) | 0.503 | 88.0/12.5 | 38.5/62.5 | 0.555 | 96.0/15.0 | 41.6/86.0 |
Portal venous wash-out (0) | 0.543 | 12.5/96.0 | 83.5/41.0 | 0.548 | 17.5/92.0 | 78.0/41.0 |
Lobulated (1) | 0.809 | 89.5/72.5 | 69.5/90.5 | 0.736 | 82.0/65.0 | 62.0/84.0 |
Pseudocapsule (1) | 0.441 | 11.0/77.5 | 25.0/55.5 | 0.536 | 32.0/75.0 | 47.5/61.0 |
Central scar (1) | 0.595 | 46.5/72.5 | 54.0/66.0 | 0.784 | 89.0/67.5 | 66.0/90.0 |
Intralesional fat (0) | 0.514 | 10.0/93.0 | 66.5/42.0 | 0.527 | 12.5/93.0 | 71.5/42.5 |
Atoll sign (0) | 0.557 | 15/96.5 | 86.0/44.0 | 0.632 | 30.0/96.5 | 92.5/49.0 |